Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by AmirKingKhan22on Feb 14, 2020 9:01am

138 Views

Post# 30690442

RE:RE:RE:Theralase Technologies Inc. v. Lanter, 2020 ONSC 205 (CanLII

This whole suit was a waste of time. There is no financial gain. The only impact it had was that lawyers had content to retweet and share on social media on cyber bullying. By the looks of it none of them were even knowledgeable on the details.

Management should look at PSS and all the criticism he has had to deal with. How does he respond? With results and NK's share appreciation.

Bullboard Posts

How one company is disrupting PoC testing